24 May 2013
Keywords: telbivudine, performs, well, hep, trial, swiss, drug
Article | 03 April 2006
Swiss drug major Novartis says that the results of a Chinese Phase III trial of its developmental nucleoside analog telbivudine, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 April 2006
© 2013 thepharmaletter.com